Casey Means, President Donald Trump’s nominee for U.S. surgeon general and an ally of Health Secretary Robert F. Kennedy Jr., is scheduled to appear on Wednesday before a key Senate committee in a long-delayed confirmation hearing.
Means, 38, was originally set to appear before the Senate’s Health, Education, Labor, and Pensions Committee in October but the hearing was rescheduled after she went into labor at 40 weeks pregnant.
As the nation’s doctor, Means would, if confirmed, advise Americans on evidence-based health practices to reduce illness and injury risks. She and her brother, Calley Means, a Trump administration adviser on food policy, are close allies of Kennedy and vocal supporters of his “Make America Healthy Again” initiative.
Means is Trump’s second nominee for the role after withdrawing his prior pick, Janette Nesheiwat, in May. Both nominations have faced opposition from far-right activists including Laura Loomer as well as establishment voices who have raised questions about her views.
She has advocated for the consumption of raw milk, repeatedly echoed Kennedy’s unscientific claims linking vaccines to autism, and criticized the use of birth control pills.
In her October prepared testimony, Means, a wellness influencer and medical doctor, said she has treated thousands of patients over 15 years in clinic settings, operating rooms, and her private practice.
There was no updated testimony available on the committee’s website ahead of Wednesday’s session.
Advertisement · Scroll to continue
STANFORD GRADUATE
Means graduated from Stanford University School of Medicine but left her surgical residency early. Her Oregon medical license is listed as “inactive,” a status Means describes as voluntary since she is not currently practicing medicine.
Means co-founded Levels, a health-tech app, and holds shares in Truemed, a company owned by her brother that assists patients in obtaining tax advantages for advanced health treatments.
Advertisement · Scroll to continue
She has pledged in her disclosure filings with the Office of Government Ethics to resign from Levels and divest her financial interests in both companies should she be confirmed.
Kennedy lauded Means during an FDA event on Tuesday as having “an extraordinary capacity to communicate to the American public” and expressed confidence she would be confirmed.
“We’ve been waiting for a long time for Dr. Means to come on board,” he said.
Reporting by Ahmed Aboulenein; Editing by David Gaffen
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Suggested Topics:
Ahmed Aboulenein
Thomson Reuters
Washington-based correspondent covering U.S. healthcare and pharmaceutical policy with a focus on the Department of Health and Human Services and the agencies it oversees such as the Food and Drug Administration, previously based in Iraq and Egypt.
Read Next
52 mins ago
Healthcare & Pharmaceuticalscategory
EQT backs out of takeover bid for UK’s Oxford Biomedica
1 hour ago
Legalcategory
Novo Nordisk partners with Vivtex in up to $2.1 billion deal for oral obesity drugs
3 hours ago
Healthcare & Pharmaceuticalscategory
Americans trust vaccines and school mandates, Reuters/Ipsos poll finds
2 hours ago
Healthcare & Pharmaceuticalscategory
UK drug regulator seizes 2,000 doses of illegal weight-loss drugs in latest crackdown
Business
Britain’s John Lewis Partnership to withdraw from build to rent business
Retail & Consumercategory · February 25, 2026 · 3:24 PM GMT+1 · 17 mins ago
British retailer the John Lewis Partnership said on Wednesday it is withdrawing from its Build to Rent property business, blaming a “fundamental shift” in the economic conditions that underpinned the venture when it launched in 2020.
Businesscategory
UK’s Revolut eyes new share sale later this year, Bloomberg News reports
18 mins ago
Energycategory
Russia plans to divert more oil revenues to budget reserve fund
22 mins ago
Explainer
Explainer: Why UK’s Reeves wants next week’s budget update to be a low-key affair
23 mins ago
Autos & Transportationcategory
US, Canada to meet in coming weeks on trade, Greer says
32 mins ago
Site Index
Latest
Home
Authors
Topic Sitemap
Archive
Article Sitemap
Media
Videos
Pictures
Graphics
Podcasts
Browse
World
Business
Markets
Sustainability
Legal
Breakingviews
Technology
Investigations
Sports
Science
Lifestyle
About Reuters
About Reuters
, opens new tab
Media Center
, opens new tab
Advertise with Us
, opens new tab
Careers
, opens new tab
Reuters News Agency
, opens new tab
Brand Attribution Guidelines
, opens new tab
Reuters and AI
, opens new tab
Reuters Leadership
, opens new tab
Reuters Fact Check
Reuters Diversity Report
, opens new tab
Commercial Disclosure (Japan)
, opens new tab
Stay Informed
Download the App (iOS)
, opens new tab
Download the App (Android)
, opens new tab
Newsletters
Subscribe
Information you can trust
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world’s media organizations, industry events and directly to consumers.
Follow Us
LSEG Products
Workspace, opens new tab
Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile.
Data Catalogue, opens new tab
Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts.
World-Check, opens new tab
Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks.
Advertise With Us
, opens new tab
Advertising Guidelines
Purchase Licensing Rights
, opens new tab
All quotes delayed a minimum of 15 minutes. See here for a list of exchanges and delays.
Cookies
, opens new tab
Terms & Conditions
Privacy
, opens new tab
Copyright
, opens new tab
Dig
ital Accessibility
, opens new tab
Corrections
Data Disclosure and Sources
, opens new tab
Site Feedback
, opens new tab
© 2026 Reuters. All rights reserved
